This report summarizes key takeaways from our October 2020 virtual roundtable on health innovation and economic growth in Japan. The report highlights the importance of health innovation in Japan and in ageing societies around the world. GCOA and the Health and Global Policy Institute (HGPI) co-organized the roundtable, which was sponsored by Pfizer Japan. The roundtable was…

This report summarizes the key takeaways from an October 2020 virtual roundtable on antimicrobial resistance (AMR) and explores the multifaceted risks posed by AMR in aging societies globally, and Japan in particular. The roundtable was co-organized by GCOA and the Health and Global Policy Institute (HGPI) and sponsored by Pfizer Japan. Click here to read the full press…

The Alliance to Beat COVID-19 (ABC) aims to encourage COVID-19 immunization for all. The goal of the initiative is to build acceptance with the hesitant, protect the most vulnerable, and facilitate uptake of the vaccine within the 60+ population. As two leaders in science and health strategy, Novim and GCOA are joining forces in our ABC…

GCOA and Pfizer Global Medical Grants launched a $1 million grant program to improve uptake of vaccines among Japanese older adults. The Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable…

In 2020, as COVID-19 spread across the globe, everything about the way we live and work changed. Workplaces quickly became virtual, cities dispersed, and a “new normal” began to take hold. For older adults, who are known to be at the greatest risk for infection, the data paints a stark reality. Adults over 80 experience…